Parallax Volatility Advisers, L.P. Rubius Therapeutics, Inc. Transaction History
Parallax Volatility Advisers, L.P.
- $45.1 Billion
- Q2 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Rubius Therapeutics, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 55,000 shares of RUBY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,000Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RUBY
# of Institutions
2Shares Held
325Call Options Held
0Put Options Held
0About Rubius Therapeutics, Inc.
- Ticker RUBY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,357,000
- Description
- Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...